Digital Health Funding and M&A

Similar documents
Venture Capital Report

Venture Capital Report

VentureSource China -- 3Q 2014

Venture Capital Report

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Venture Capital Report

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010

VentureSource U.S. -- 4Q 2013

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

VentureSource China -- 1Q 2014

Israel Venture Capital Investments Report Q3 2017

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000

Overview of Venture Equity

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

2O2O WOMEN ON BOARDS GENDER DIVERSITY INDEX

2013 venture capital trends summary

Venture Capital Report

Venture Capital Report

VentureSource Europe -- 3Q 2014

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Silicon Valley Venture Capital Survey Second Quarter 2018

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Venture Capital Report

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

NOTICE To the Trustee of

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MoneyTreeTM. Report. Some $171 million VC financing invested in hi-tech companies in Q compared with $255 million in the second quarter 2012

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Average M&A Deal Size at Highest Level Since 2004

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GLOBAL PRIVATE EQUITY Report Charts

Chartwell Introduction and AEC Capabilities

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT

The percentage of Series A rounds declined significantly, to 12% of all deals.

MANGROVE EQUITY PARTNERS

Purvi B. Maniar Member of the Firm

Silicon Valley Venture Capital Survey Third Quarter 2017

KKR and FS Investments Form Strategic BDC Partnership Creates the Leading $18BN Alternative Lending Platform. December 2017

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Financing Baltimore s Growth: Venture Capital Support for Small Companies

Venture Capital Industry Overview. Powered By:

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Venture Capital Report

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

KKR & Co. L.P. Goldman Sachs U.S. Financial Services Conference: December 6, 2017

Technologies Worth Watching. Case Study: Investigating Innovation Leader s

Venture Capital & Private Equity in India. Last Update: October

Trends in Healthcare Investments and Exits 2018

Q INTRODUCTION VC ACTIVITY OVERVIEW. Summary of investment and fundraising. ($ millions)

Mary Macdonald November 2005

Robert A. Greising Partner

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Q Q Cleantech Investment Monitor VOL. 7 / ISSUE 1.

Mara H. Rogers, Partner Norton Rose Fulbright

The Next Silicon Valley Investment Feeding Frenzy

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

S&P Global Market Intelligence, KPMG and ACG

TENOR CAPITAL PARTNERS. ESOP Leveraged Buyout Specialist,

Shaking the MoneyTree TM Q Update

HOW TO READ A PATENT. To Understand a Patent, It is Essential to be able to Read a Patent. ATIP Law 2014, All Rights Reserved.

KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018

Raising Capital. Get the Money You Need to Grow Your Business. Third Edition. Andrew J. Sherman

MILLENNIUM REPORTS ON RECENT ACTIVITIES AND NEW TRENDS SHAPING THE FUTURE OF THE VENTURE CAPITAL ECOSYSTEM

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VENTURE CAPITAL MONITOR

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mergers and Acquisitions/ Private Equity. Providing In-Depth Deal Coverage for Buyers, Sellers, and Investors. Attorney Advertising

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Year In Review: 2017 Edition

2 nd Quarter Earnings Conference Call

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp

Angel Group Update: Q2 2013

Venture Capital Report

About Us LET US HELP YOU!

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Shaking the MoneyTree TM Q Update

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transcription:

Digital Health Funding and M&A 2018 Third Quarter and Nine Month Report Funding and Merger & Acquisition activity for the Digital Health sector http://www.mercomcapital.com 1 Copyright 2010-2016 Mercom Capital Group www.mercomcapital.com hit@mercomcapital.com

About Mercom s Digital Health Funding and M&A Report Mercom was one of the first research firms to track funding and M&A activity in the Digital Health (Healthcare IT) sector since 2010 and has a comprehensive deal history. Here is how Mercom s report is different: Our report includes deals of all sizes, globally, to present a complete picture of Digital Health funding and technology trends. As an independent research firm, we have no conflicts of interest with companies covered in this report. This is the most comprehensive report covering funding and M&A deals of all sizes, globally. The trends revealed in this report give a more complete picture of the industry. All charts, graphs, and trends are clearly categorized and defined by technology and subtechnology groups. This report includes concise deal information for every transaction. This report covers historical trends. As the industry evolves, our report evolves with it and we continuously improve the information, analysis, charts, and trends covered every quarter. Our subscribers include companies and executives from venture capital, private equity, investment banking, healthcare, insurance, healthcare associations, universities, tech firms, and more. Audience Venture Capital/Private Equity Investment bankers Healthcare IT, Digital health Why they like our reports leads from early-stage deals, technology trends leads for funding and M&A deals, investor leads sector trends, investor targets (by funding behavior, including technology, technology partnership targets, and more) Insurance companies Large healthcare & Tech firms acquisition leads, investment leads, technology partnerships acquisition leads, R&D partnerships, investment leads 2 Copyright 2010-2018 Mercom Capital Group www.mercomcapital.com hit@mercomcapital.com

SELECT KEY FINDINGS Global VC funding for Digital Health companies totaled $3.1 billion in 173 deals in Q3 2018 compared to $2.4 billion in 196 deals in Q2 2018. Digital Health VC Funding 9M 2014-9M 2018 9,000 8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 9M'14 9M'15 9M'16 9M'17 9M'18 700 600 500 400 300 200 100 0 Disclosed Amount (US$M) No. of Deals Source: Mercom Capital Group Healthcare Practice-Focused companies secured $1.3 billion in 62 deals, accounting for 40 percent of the $3.1 billion in total VC funding that went into the Digital Health sector in Q3 2018. Healthcare Consumer-Centric companies raised more than $1.9 billion in 111 deals in Q3 2018. The top funded categories in Q3 2018 were: Data Analytics companies with $889 million, mhealth Apps companies with $504 million, Mobile Wireless companies with $456 million, and Telemedicine with $374 million. The average deal size in Q3 2018 was $18.4 million compared to the $12.8 million average in Q2 2018 (excluding accelerator deals). There were 24 countries that saw Digital Health VC funding deals in Q3 2018 compared to 22 countries in Q2 2018. American companies received the most VC funding and had the most deals. 3 Copyright 2010-2018 Mercom Capital Group www.mercomcapital.com hit@mercomcapital.com

International VC funding came to $932 million in Q3 2018 compared to $664 million in Q2 2018. Within the United States, 36 deals originated from California followed by New York with 14, Massachusetts with 11, Florida with six, then Minnesota and Tennessee had four deals each. Announced debt and public market financing for Digital Health companies fell $398 million in six deals in Q3 2018, compared to $2 billion in six deals in Q2 2018. In 9M 2018, there were a total of 172 M&A transactions compared to 146 in 9M 2017. A total of 419 investors made investments in Digital Health companies in Q3 2018. Top Digital Health M&A Transactions in Q3 2018 By Disclosed Amount Company Terms/Amount ($M) Acquirer Country 800 USA 700 USA 217 USA (Rhapsody and Population Health Business) 152 USA 50 USA Source: Mercom Capital Group 4 Copyright 2010-2018 Mercom Capital Group www.mercomcapital.com hit@mercomcapital.com

. Digital Health VC Funding By Amount in 9M 2018 (US$ in Millions) 2000 1800 1600 1400 1200 1000 800 600 400 200 0 Data Analytics Telemedicine mhealth Apps Source: Mercom Capital Group 5 Copyright 2010-2018 Mercom Capital Group www.mercomcapital.com hit@mercomcapital.com

TABLE of CONTENTS Introduction.... 3 Key Findings... 5 2017-2018 Digital Health Funding and M&A... 9 VC Funding 2010-2018 YTD... 9 VC Funding by Quarter..... 10 VC Funding by Technology.. 11 Q3 2018 Funding Breakdown.. 12 9M 2018 Funding Breakdown.. 13 Practice-focused VC Funding by Sub-Technology.. 14 Health Information Management..... 15 Consumer-focused VC Funding by Technology.. 20 Mobile Health......... 21 Telehealth...... 29 Personal Health....... 32 Scheduling, Rating & Shopping...... 34 Social Health...... 35 VC Funding by Stage..... 36 VC Activity by Country... 38 VC Activity by U.S. States.... 40 Top VC Funding Deals........ 42 Top VC Investors....... 44 Accelerators/Incubators...... 45 VC Deals.... 46 VC Investors........ 64 Debt and Public Market Financing.. 83 Debt and Public Market Financing Activity....... 85 Initial Public Offering (IPO)... 86 Mergers and Acquisitions (M&A). 88 M&A by Technology...... 90 M&A by Sub-Technology............. 93 Q3 2018 M&A Breakdown.. 94 9M 2018 M&A Breakdown.. 95 Top M&A Transactions.... 96 Active Acquirers... 98 M&A Transactions by Country... 99 M&A Transactions.. 100 New Healthcare Investment Funds...... 106 Restructuring and Downsizing... 106 6 Copyright 2010-2018 Mercom Capital Group www.mercomcapital.com hit@mercomcapital.com

Get the Full Report including 2017 First Quarter Healthcare IT Funding and M&A Transaction Tables Click here to purchase Mercom s Q3 and 9M 2018 Digital Health Funding and M&A Report Includes transactions and investor lists Subscribe to Mercom s weekly Digital Health Market Intelligence report and Digital Health Deals newsletter Visit: MercomCapital.com to purchase past reports DISCLAIMER: 2018 by Mercom Capital Group, llc. All rights reserved. Mercom hereby grants user a personal, non-exclusive, non-refundable, non-transferable license to use the Report for research purposes only. Mercom retains exclusive and sole ownership of all its Reports. When quoting from this report, please cite Mercom Capital Group, llc. Information contained in this publication is derived from carefully selected sources we believe to be reliable. Mercom, its employees, affiliates, agents, and licensors do not warrant the accuracy, completeness, correctness, noninfringement, 7 merchantability, Copyright or 2010-2017 fitness for a particular Mercom Capital purpose Group of this report. www.mercomcapital.com Nothing in this report constitutes hit@mercomcapital.com or should be taken as investment advice. For information about this document, please contact us at 512-215-4452 or via email at: HIT@mercomcapital.com.